Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets

Indian Journal of Medical Research

Volumn 122, Issue 3, 2005, Pages 199-204

  Rao, Ramakrishna U ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Brugia malayi; Diethylcarbamazine; Doxycycline; Embryogenesis; Endobacteria; Filariasis; Onchocerca volvulus; Rickettsia; Wolbachia; Wuchereria bancrofti

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CHLORAMPHENICOL; DIETHYLCARBAMAZINE; DOXYCYCLINE; IVERMECTIN; LIPOSOME; MINOCYCLINE; OXYTETRACYCLINE; RIFAMPICIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE;

BACTERIUM IDENTIFICATION; BANGLADESH; BODY FLUID; BRUGIA; BRUGIA MALAYI; CLINICAL TRIAL; DEVELOPMENTAL STAGE; DISEASE TRANSMISSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EMBRYO DEVELOPMENT; ENDOSYMBIOSIS; EYE INJURY; FILARIASIS; HUMAN; INDIA; INFECTION RISK; LIFE CYCLE; LYMPHATIC SYSTEM INFECTION; MALDIVES; MICROFILARIA; NEMATODIASIS; NEPAL; NONHUMAN; ONCHOCERCIASIS; PARASITE VECTOR; PARASITOSIS; PREVALENCE; REVIEW; RICKETTSIACEAE; SIDE EFFECT; SPECIES; SRI LANKA; VERTICAL TRANSMISSION; WOLBACHIA; WUCHERERIA BANCROFTI;

ANIMALS; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FILARIASIS; HUMANS; INDIA; REPRODUCTION; SYMBIOSIS; WOLBACHIA; WUCHERERIA BANCROFTI;

EID: 27844490028     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. McLaren DJ, Worms M, Laurence B, Simpson M. Microorganisms in filarial larvae (Nematoda). Tran R Soc Trop Med Hyg 1975; 69: 509-14.
2. Kozek W. Transovarially-transmitted intracellular microorganisms in adult and larval stages of Brugia malayi. J Parasitol 1977; 63: 992-1000.
3. Kozek W, Marroquin H. Intracytoplasmic bacteria in Onchocerca volvulus. Am J Trop Med Hyg 1977; 26: 663-78.
4. McGarry HF, Egerton GL, Taylor MJ. Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi. Mol Biochem Parasitol 2004; 135: 57-67.
5. Fenn K, Blaxter M. Quantification of Wolbachia bacteria in Brugia malayi through the nematode lifecycle. Mol Biochem Parasitol 2004; 137: 361-4.
6. Taylor MJ, Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitol Today 1999; 15: 437-42.
7. Casiraghi M, Bain O, Guerrero R, Martin C, Pocacqua V, Gardner SL, et al. Mapping the presence of Wolbachia pipientis on the phylogeny of filarial nematodes: evidence for symbiont loss during evolution. Int J Parasitol 2004; 34: 191-203.
8. Büttner DW, Wanji S, Bazzocchi C, Bain O, Fischer P. Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa. Filaria J 2003; 9: 10.
9. Chirgwin SR, Porthouse KH, Nowling JM, Klei TR. The filarial endosymbiont Wolbachia sp. is absent from Setaria equina. J Parasitol 2002; 88: 1248-50.
10. Bandi C, Anderson TJC, Genchi C, Blaxter ML. Phylogeny of Wolbachia in filarial nematodes. Proc R Soc London B Biol Sci 1998; 265: 2407-13.
11. Casiraghi M, Anderson TJC, Bandi C, Bazzocchi C, Genchi C. A phylogenetic analysis of filarial nematodes: comparison with the phylogeny of Wolbachia endosymbionts. Parasitology 2001; 122: 93-103.
12. Smith HL, Rajan TV. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro. Exp Parasitol 2000; 95: 265-70.
13. Rao R, Weil GJ. In vitro effects of antibiotics on Brugia malayi worm survival and reproduction. J Parasitol 2002; 88: 605-11.
14. Rajan TV. Relationship of anti-microbial activity of tetracyclines to their ability to block the L3 to L4 molt of the human filarial parasite Brugia malayi. Am J Trop Med Hyg 2004; 71: 24-8.
15. Casiraghi M, McCall JW, Simoncini L, Kramer LH, Sacchi L, Genchi C, et al. Tetracycline treatment and sex-ratio distortion: a role for Wolbachia in the moulting of filarial nematodes? Int J Parasitol 2002; 32: 1457-68.
16. Bosshardt SC, McCall JW, Coleman SU, Jones KL, Petit TA, Klei TR. Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unguiculatus). J Parasitol 1993; 79: 775-7.
17. McCall JW, Jun JJ, Bandi C. Wolbachia and the antifilarial properties of tetracycline. An untold story. Italian J Zool 1999; 66: 7-10.
18. Rao R, Moussa H, Weil GJ. Brugia malayi: Effects of antibacterial agents on larval viability and development in vitro. Exp Parasitol 2002; 101: 77-81.
19. Hoerauf A, Nissen-Pàehle, K, Schmetz C, Henkle-Dührsen, K, Blaxter, M L, Büttner D W, et al. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 1999; 103: 11-8.
20. Hoerauf A, Volkmann L, Nissen-Pàehle, K, Schmetz C, Autenrieth I, Büttner DW, et al. Targetting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxin. Trop Med Int Health 2000; 5: 275-9.
21. Langworthy NG, Renz A, Meckenstedr U, Henkle-Dührsen K, Bronsvoort M, Tanya VN, et al. Macrofilaricidal activity of tetracycline against the filarial nematode, Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc R Soc London Series B 2000; 267: 1063-9.
22. Townson S, Hutton D, Siemienska J, Hollick L, Scanlon, T, Tagboto SK, et al. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Ann Trop Med Parasitol 2000; 94: 801-16.
23. Bandi C, McCall J W, Genchi C, Corona S, Venco L, Sacchi L. Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol 1999; 29: 357-64.
24. Volkmann L, Fischer K, Taylor M, Hoerauf A. Antibiotic therapy in murine filariasis (Litomosoides carinii): Comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability. Trop Med Int Health 2003; 8: 392-401.
25. Sacchi L, Corona S, Kramer L, Calvi L, Casiraghi M, Franceschi A. Ultrastructural evidence of the degenerative events occurring during embryogenesis of the filarial nematode Brugia pahangi after tetracycline treatment. Parasitologia 2003; 45: 89-96.
26. Kramer LH, Passeri B, Corona S, Simoncini L, Casiraghi M. Immunohistochemical/immunogold detection and distribution of the endosymbiont Wolbachia of Dirofilaria immitis and Brugia pahangi using a polyclonal antiserum raised against WSP (Wolbachia surface protein). Parasitol Res 2003; 89: 381-6.
27. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fliescher B, et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 2000; 355: 1242-3.
28. Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfiladermia after ivermectin treatment. Lancet 2001; 357: 1415-6.
29. Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y, Taylor M, et al. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 2003; 5: 261-73.
30. Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, et al. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol 2003; 192: 211-6.
31. Brouqui P, Fournier PE, Raoult D. Doxycycline and eradication of microfilaremia in patients with loiasis. Emerg Infect Dis 2001; 7: 604-5.
32. Walgate R. Could antibiotics cure river blindness? Bull World Health Organ 2002; 80: 336.
33. http://tools.neb.com/wolbachia, accessed on October 2004.
34. Foster J, Ganatra M, Kamal I, Ware J, Makarova K, Ivanova N, et al. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol 2005; 3: e121.
35. Devaney E, Yazdanbakhsh M. Prospects and challenges in lymphatic filariasis. Parasite Immunol 2001; 23: 323-5.
36. Freeing the World of LF: A call to action. 3rd meeting of the Global Alliance to Eliminate Lymphatic Filariasis. March 2004; 1-22.
37. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 2003; 19: 516-22.
38. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382-6.
39. Ottesen EA. Major progress toward eliminating lymphatic filariasis. N Engl J Med 2002; 347: 1885-6.
40. Melrose WD. Chemotherapy for lymphatic filariasis: progress but not perfection. Expert Rev Anti Infect Ther 2003; 1: 571-7.
41. Sabesan S, Ravi R, Das PK. Elimination of lymphatic filariasis in India. Lancet Infect Dis 2005; 5: 4-5.
42. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Arunachalam N, et al. Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India. Trans R Soc Trop Med Hyg 2004; 98: 174-81.
43. Taylor MJ, Hoerauf A. A new approach to the treatment of filariasis. Curr Opin Infect Dis 2001; 14: 727-31.
44. Hoerauf A, Adjei O, Büttner DW. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Investig Drugs 2002; 3: 533-7.
45. Rao R. Wolbachia in worms: endosymbiont of parasitic filarial nematodes. Recent Res Develop Ex Med TransWorld Research Network Publications (Kerala, India). 2004; 1: 95-113.
46. Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother 2005; 49: 220-9.
47. Sangare L, Morisset R, Omri A, Ravaoarinoro M. Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum. J Antimicrob Chemother 1998; 42: 831-4.
48. Sangare L, Morisset R, Ravaoarinoro M. In vitro antichlamydial activities of free and liposomal tetracycline and doxycycline. J Med Microbiol 1999; 48: 689-93.
49. Bakker-Woudenberg IA, Schiffelers RM, Storm G, Becker MJ, Guo L. Long-circulating sterically stabilized liposomes in the treatment of infections. Methods Enzymol 2005; 391: 228-60.
50. McFadden GI, Roos DS. Apicomplexan plastids as drug targets. Trends Microbiol 1999; 7: 328-33.
51. Wilson RJ. Parasite plastids: approaching the endgame. Biol Rev Camb Philos Soc 2005; 80: 129-53.